A population-based cohort study emulating a target trial estimated the effect of glucagon-like peptide-1 receptor agonists ...

Glucagon-like peptide 1 receptor agonists may offer neuroprotective and survival benefits beyond blood sugar control.

GLP-1 RAs used by adults with type 2 diabetes and obesity is linked to lower risk for dementia, stroke, and mortality vs ...

In older patients with cancer and type 2 diabetes, glucagon-like peptide-1 receptor agonist (GLP-1RA) use was associated with ...

For adults with overweight or obesity, certain factors might influence weight loss after taking glucagon-like peptide 1 receptor agonists (GLP-1 RAs).

In a joint clinical practice guideline issued by the Endocrine Society and European Society of Endocrinology, recommendations ...

Newsweek spoke to some experts about whether the weight loss drug could have an impact on birth rates in America.

The agreement, signed Monday between CMS and DHS, has not been announced publicly, AP reports. Other Trump administration ...

A sharp drop is also expected in the federal subsidies that most consumers depend on to buy ACA plans. Also in the news: a lawsuit to block Obamacare changes, the challenge of tracking Medicaid ...